Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23374423)

1.

Two novel approaches targeting cancer cell membrane for tumor therapy.

Feng Y, Wang B, Cao Y, He R.

Med Hypotheses. 2013 Apr;80(4):380-2. doi: 10.1016/j.mehy.2012.12.025. Epub 2013 Jan 29.

PMID:
23374423
2.

Molecular-targeted therapy for cancer.

Dong B, Zhu YM.

Chin J Cancer. 2010 Mar;29(3):340-5. Review.

3.

Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.

McDonald PC, Winum JY, Supuran CT, Dedhar S.

Oncotarget. 2012 Jan;3(1):84-97. Review.

4.

Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain.

Zatovicova M, Jelenska L, Hulikova A, Csaderova L, Ditte Z, Ditte P, Goliasova T, Pastorek J, Pastorekova S.

Curr Pharm Des. 2010;16(29):3255-63. Review.

PMID:
20819068
5.

Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.

Ralph SJ, Low P, Dong L, Lawen A, Neuzil J.

Recent Pat Anticancer Drug Discov. 2006 Nov;1(3):327-46. Review.

PMID:
18221044
6.
7.
8.

The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.

Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Review.

PMID:
20206201
9.

Radiation-induced bystander and other non-targeted effects: novel intervention points in cancer therapy?

Mothersill C, Seymour C.

Curr Cancer Drug Targets. 2006 Aug;6(5):447-54. Review.

PMID:
16918311
10.

Photochemical internalization of tumor-targeted protein toxins.

Weyergang A, Selbo PK, Berstad ME, Bostad M, Berg K.

Lasers Surg Med. 2011 Sep;43(7):721-33. doi: 10.1002/lsm.21084. Review.

PMID:
22057500
11.
12.

Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.

Aziz K, Nowsheen S, Georgakilas AG.

Curr Mol Med. 2010 Oct;10(7):626-39. Review.

PMID:
20712589
13.

Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization).

Rabussay DP, Nanda GS, Goldfarb PM.

Technol Cancer Res Treat. 2002 Feb;1(1):71-82.

PMID:
12614180
14.

Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.

Sultana S, Khan MR, Kumar M, Kumar S, Ali M.

J Drug Target. 2013 Feb;21(2):107-25. doi: 10.3109/1061186X.2012.712130. Epub 2012 Aug 9. Review.

PMID:
22873288
15.

Approaches for targeting mitochondria in cancer therapy.

D'Souza GG, Wagle MA, Saxena V, Shah A.

Biochim Biophys Acta. 2011 Jun;1807(6):689-96. doi: 10.1016/j.bbabio.2010.08.008. Epub 2010 Aug 21. Review.

16.

Targeted cancer therapy: conferring specificity to cytotoxic drugs.

Chari RV.

Acc Chem Res. 2008 Jan;41(1):98-107. Epub 2007 Aug 18. Review.

PMID:
17705444
17.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
18.

Anticancer activities of anti-membrane antibodies against colon carcinoma cells undergoing chemotherapy.

Huang C, Zhu Y, Jiang Y, Li Z, Yao J, Duan G, Li D, Wang Q.

Tumori. 2013 Jan-Feb;99(1):113-20. doi: 10.1700/1248.13798.

PMID:
23549010
19.

A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.

Kawamoto M, Horibe T, Kohno M, Kawakami K.

BMC Cancer. 2011 Aug 18;11:359. doi: 10.1186/1471-2407-11-359.

20.

Anticancer platinum (IV) prodrugs with novel modes of activity.

Chin CF, Wong DY, Jothibasu R, Ang WH.

Curr Top Med Chem. 2011;11(21):2602-12. Review.

PMID:
22039869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk